MedPath
FDA Approval

METHADONE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 26, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Methadone(10 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

West-Ward Columbus Inc.

Hikma Pharmaceuticals USA Inc.

058839929

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METHADONE HYDROCHLORIDE

Product Details

NDC Product Code
0054-0710
Application Number
ANDA088109
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 1, 2021
MethadoneActive
Code: 229809935BClass: ACTIBQuantity: 10 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT

METHADONE HYDROCHLORIDE

Product Details

NDC Product Code
0054-0709
Application Number
ANDA088108
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 1, 2021
MethadoneActive
Code: 229809935BClass: ACTIBQuantity: 5 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
© Copyright 2025. All Rights Reserved by MedPath